GSK lifts profit and sales forecasts after quarterly beat
British drugmaker GSK has today raised its annual earnings and sales forecasts after beating second-quarter expectations on strong sales of its cancer and HIV treatments, but its weak vaccines sales and outlook weighed on the shares.
Business
• 31 Jul 24